KeyVac, founded in Ankara in 2021, is a leading Turkish biopharmaceutical company established as a joint venture between Alagöz Holding and Sinovac Biotech Ltd. Specializing in vaccine production based on proven inactivated technology, the company plays a key role in ensuring equitable access to COVID-19 vaccines in Türkiye and global markets. With advanced manufacturing infrastructure and robust quality control systems, KeyVac delivers reliable, high-standard healthcare solutions. Focused on innovation and public health, the company continues to contribute to global immunization efforts.

Koç İlaç Sanayi ve Ticaret A.Ş., founded in 2006 with 100% domestic capital, is a trusted Turkish manufacturer operating in the healthcare and pharmaceutical sector. Leveraging strong industry expertise and a qualified team, the company provides contract manufacturing services for nearly 30 local and 35 international partners. With proven export experience to markets such as Afghanistan, Azerbaijan, Kosovo, and Iraq, Koç İlaç continues to strengthen its global presence. Committed to its “People First” philosophy, the company delivers reliable, high-quality healthcare products aligned with international standards.

GEN is a Türkiye-based pharmaceutical company focused on developing and delivering innovative treatments for rare diseases and unmet medical needs. Established in 1998, the company operates advanced manufacturing and R&D facilities, producing high-quality pharmaceutical products for global healthcare markets. With international GMP approvals and a strong research infrastructure, GEN develops both original and generic medicines while expanding its presence across Europe, Central Asia, and other international markets. Through continuous innovation, strategic partnerships, and global expansion, GEN aims to be a leading international pharmaceutical company.

Elixir is a Türkiye-based pharmaceutical research and development company focused on developing innovative drug products and advanced manufacturing processes for the global pharmaceutical industry. Established in 2014, the company operates high-technology laboratories and develops pharmaceutical formulations in compliance with EMA and FDA standards. Elixir provides technology transfer services to pharmaceutical manufacturing facilities and collaborates with partners across Türkiye, Europe, and the United States. As part of GEN since 2019, the company contributes to international drug development programs through strong scientific infrastructure and export-oriented R&D capabilities.

Dinçsa İlaç Sanayi ve Ticaret A.Ş., established in 1973, is a pharmaceutical manufacturer dedicated to improving human health through high-quality and reliable medicine production. Operating from its production facility in Ankara 1st Organized Industrial Zone since 1998, the company focuses on developing equivalent medicines that add value to the national economy. With a strong R&D-driven culture, Dinçsa continuously invests in innovation, technology, and human capital to support healthier lives both in Türkiye and beyond.

ABAvac is a biotechnology company focused on R&D in the field of animal health since 2013. The company is dedicated to producing high-tech Foot-and-Mouth Disease (FMD) vaccines under GMP standards and collaborates with both domestic and international universities to develop innovative biotechnological solutions. With its expert team and advanced infrastructure, ABAvac aims to become the leading GMP-certified veterinary vaccine manufacturer in Türkiye, the Middle East, and Africa. Embracing the One Health approach, the company works with the belief that human health is inseparable from the health of animals and the environment.